ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 292 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $54,026 | -21.4% | 2,127 | +25.6% | 0.01% | -30.0% |
| Q4 2022 | $68,709 | +10.8% | 1,694 | -9.1% | 0.01% | 0.0% |
| Q3 2022 | $62,000 | -6.1% | 1,863 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $66,000 | -35.3% | 1,863 | -15.7% | 0.01% | -33.3% |
| Q1 2022 | $102,000 | -29.7% | 2,211 | +1.1% | 0.02% | -28.6% |
| Q4 2021 | $145,000 | +8.2% | 2,188 | +1.7% | 0.02% | +5.0% |
| Q3 2021 | $134,000 | -40.7% | 2,151 | -21.3% | 0.02% | -47.4% |
| Q2 2021 | $226,000 | +24.2% | 2,732 | -0.4% | 0.04% | -50.6% |
| Q1 2021 | $182,000 | -13.7% | 2,743 | -0.2% | 0.08% | -18.1% |
| Q4 2020 | $211,000 | +78.8% | 2,748 | 0.0% | 0.09% | +100.0% |
| Q3 2020 | $118,000 | -5.6% | 2,748 | -4.7% | 0.05% | -11.3% |
| Q2 2020 | $125,000 | +50.6% | 2,885 | 0.0% | 0.05% | +29.3% |
| Q1 2020 | $83,000 | -74.8% | 2,885 | -44.6% | 0.04% | -68.0% |
| Q4 2019 | $330,000 | +126.0% | 5,207 | +0.2% | 0.13% | +96.9% |
| Q3 2019 | $146,000 | +4.3% | 5,198 | -1.9% | 0.06% | +3.2% |
| Q2 2019 | $140,000 | +2233.3% | 5,298 | +1609.0% | 0.06% | +2000.0% |
| Q1 2019 | $6,000 | 0.0% | 310 | -39.2% | 0.00% | +50.0% |
| Q4 2018 | $6,000 | +50.0% | 510 | +142.9% | 0.00% | 0.0% |
| Q3 2018 | $4,000 | +300.0% | 210 | +90.9% | 0.00% | – |
| Q2 2018 | $1,000 | – | 110 | +1000.0% | 0.00% | – |
| Q1 2018 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 10 | -90.0% | 0.00% | – |
| Q2 2017 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 100 | -75.0% | 0.00% | -100.0% |
| Q4 2016 | $1,000 | -87.5% | 400 | -63.6% | 0.00% | -75.0% |
| Q3 2016 | $8,000 | +14.3% | 1,100 | -21.4% | 0.00% | 0.0% |
| Q2 2016 | $7,000 | – | 1,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |